EPID – a useful interfraction QC tool

[1] Herman MG, Balter JM, Jaffray DA, et al. Clinical use of electronic portal imaging: Report of AAPM Radiation Therapy Committee Task Group 58. Med Phys. 2001;28(5):712-737.10.1118/1.1368128Search in Google Scholar

[2] Herman MG, Kruse JJ, Hagness CR. Guide to clinical use of electronic portal imaging. J Appl Clin Med Phys. 2000;1(2):38-57.10.1120/jacmp.v1i2.2645Search in Google Scholar

[3] Bogaerts R, Van Esch A, Reymen R, Huyskens D. A method to estimate the transit dose on the beam axis for verification of dose delivery with portal images. Radiother Oncol. 2000;54(1):39-46.10.1016/S0167-8140(99)00165-6Search in Google Scholar

[4] Pasma KL, Kroonwijk M, Quint S, et al. Transit dosimetry with an electronic portal imaging device (EPID) for 115 prostate cancer patients. Int J Radiat Oncol Biol Phys. 1999;45(5):1297-1303.10.1016/S0360-3016(99)00328-4Search in Google Scholar

[5] Kroonwijk M, Pasma KL, Quint S, et al. In vivo dosimetry for prostate cancer patients using an electronic portal imaging device (EPID); demonstration of internal organ motion. Radiother Oncol. 1998;49(2):125-132.10.1016/S0167-8140(98)00122-4Search in Google Scholar

[6] Huyskens D, Van Dam J, Dutreix A. Midplane dose determination using in vivo dose measurements in combination with portal imaging. Phys Med Biol. 1994;39(7):1089-1101.10.1088/0031-9155/39/7/003Search in Google Scholar

[7] Woźniak B, Ganowicz M, Bekman A, Maniakowski Z. A comparison of the dosimetric properties of The Electronic Portal Imaging Devices (EPIDs) LC250 and aS500. Rep Pract Oncol Radiother. 2005;10(5):249-254.10.1016/S1507-1367(05)71097-XSearch in Google Scholar

[8] Ganowicz M, Woźniak B, Bekman A, Maniakowski Z. Using an electronic portal imaging device for exit dose measurements in radiotherapy. Nowotwory J Oncol. 2003;53(6):626-629.Search in Google Scholar

[9] Ding GX, Munro P. Comparing MV And kV Imaging Doses For Image Guided Radiation Therapy. Proceedings of the 53rd Annual ASTRO Meeting. Int J Radiat Oncol Biol Phys. 2011;81(2 Supp):S771-S77210.1016/j.ijrobp.2011.06.1191Search in Google Scholar

[10] Boas FE, Fleischmann D. CT artifacts: Causes and reduction techniques. Imaging Med. 2012;4(2):229-240.10.2217/iim.12.13Search in Google Scholar

[11] Li H, Noel C, Chen H, et al. Clinical evaluation of a commercial orthopedic metal artifact reduction tool for CT simulations in radiation therapy. Med Phys. 2012;39(12):7507-7517.10.1118/1.4762814361809523231300Search in Google Scholar

[12] Boas FE, Fleischmann D. Evaluation of Two Iterative Techniques for Reducing Metal Artifacts in Computed Tomography. Radiology. 2011;259(3):894-902.10.1148/radiol.1110178221357521Search in Google Scholar

[13] van Zijtveld M, Dirkx ML, de Boer HC, Heijmen BJ. Dosimetric pre-treatment verification of IMRT using an EPID; clinical experience. Radiother Oncol. 2006;81(2):168-175.10.1016/j.radonc.2006.09.00817055604Search in Google Scholar

[14] Wendling M, Louwe RJ, McDermott LN, et al. Accurate two-dimensional IMRT verification using a back-projection EPID dosimetry method. Med Phys. 2006;33(2):259-273.10.1118/1.214774416532930Search in Google Scholar

[15] McDermott LN, Wendling M, Sonke JJ, et al. Replacing pretreatment verification with in vivo EPID dosimetry for prostate IMRT. Int J Radiat Oncol Biol Phys. 2007;67(5):1568-1577.10.1016/j.ijrobp.2006.11.04717394951Search in Google Scholar

[16] McDermott LN, Wendling M, Nijkamp J, et al. 3D in vivo dose verification of entire hypo-fractionated IMRT treatments using an EPID and cone-beam CT. Radiother Oncol. 2008;86(1):35-42.10.1016/j.radonc.2007.11.01018061692Search in Google Scholar

[17] van Elmpt W, Nijsten S, Mijnheer B, et al. The next step in patient-specific QA: 3D dose verification of conformal and intensity-modulated RT based on EPID dosimetry and Monte Carlo dose calculations. Radiother Oncol. 2008;86(1):86-92.10.1016/j.radonc.2007.11.00718054102Search in Google Scholar

[18] van Elmpt W, Nijsten S, Petit S, et al. 3D in vivo dosimetry using megavoltage, cone-beam CT and EPID dosimetry. Int J Radiat Oncol Biol Phys. 2009;73(5):1580-1587.10.1016/j.ijrobp.2008.11.05119306755Search in Google Scholar

[19] van Elmpt W, Petit S, De Ruysscher D, et al. 3D dose delivery verification using repeated cone-beam imaging and EPID dosimetry for stereotactic body radiotherapy of non-small cells lung cancer. Radiother Oncol. 2010;94(2):188-194.10.1016/j.radonc.2009.12.02420083317Search in Google Scholar

[20] Mijnheer B, Olaciregui-Ruiz I, Rozendaal R, et al. 3D EPID – based in vivo dosimetry for IMRT and VMAT. J Phys: Conf Series. 2013;444:012011.10.1088/1742-6596/444/1/012011Search in Google Scholar

[21] van Zijtveld M, Dirkx ML, de Boer HC, Heijmen BJ. 3D dose reconstruction for clinical evaluation of IMRT pretreatment verification with an EPID. Radiother Oncol. 2017;82(2):201-207.10.1016/j.radonc.2006.12.01017287039Search in Google Scholar

[22] TRUEBEAM STx System Specifications. Available at : varian.com.Search in Google Scholar

[23] Eclipse Photon and Electron Algorithms Reference Guide, P1008611-002-B, Varian Medical Systems (September 2014).Search in Google Scholar

[24] Portal Dosimetry Reference Guide, P1001364B, Varian Medical Systems (2013).Search in Google Scholar

[25] Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation of dose distributions. Med Phys. 1998;25(5): 656-661.10.1118/1.5982489608475Search in Google Scholar

[26] Slosarek K, Szlah M, Bekman B, Grzadziel A. EPID in vivo dosimetry in RapidArc technique. Rep Pract Oncol Radiother. 2010;15(1):8-14.10.1016/j.rpor.2010.01.003386328924376916Search in Google Scholar

[27] Fidanzio A, Cilla S, Greco F, et al. Generalized EPID calibration for in vivo transit dosimetry. Phys Med. 2011;27(1):30-38.10.1016/j.ejmp.2010.02.00220199885Search in Google Scholar

[28] Valve A, Keyriläinen J, Kulmala J. Compass model-based quality assurance for stereotactic VMAT treatment plans. Phys Med. 2017;44:42-50.10.1016/j.ejmp.2017.11.00929254590Search in Google Scholar

[29] Nakaguchi Y, Ono T, Maruyama M, et al. Validation of a method for in vivo 3D dose reconstruction in SBRT using a new transmission detector. J Appl Clin Med Phys. 2017;18(4):69-75.10.1002/acm2.12103587485928574221Search in Google Scholar